CD3CD20MBS303BI…

mbs303MBS 303 is a bispecific antibody targeting CD3CD20 being developed by Beijing Mabworks Biotech for the treatment of B cell non-Hodgkin lymphoma. TheFind the best pricing for Yageo MBS303-B-AX-0RAA by comparing bulk discounts from 4 distributors. Octopart is the world's source for MBS303-B-AX-0RAA availability, pricing,